Table 2

Male circumcision prevalence and selected infectious diseases among developing countries.

Univariate linear regression of male circumcision prevalence1

Countries with low (<20%) male circumcision prevalence

Countries with high (>80%) male circumcision prevalence




No. of countries

Regression coefficient

R2*

No. of countries

Mean ± SD*

No. of countries

Mean ± SD*



HIV prevalence among sub-Saharan Africa (/100 adults)2

38

-0.90

0.51

8

16.48 ± 0.002

22

2.98 ± 0.002

HIV prevalence among non-sub-Saharan African countries with primarily heterosexual HIV transmission (/100 adults)2

29

-1.08

0.51

11

0.76 ± 0.004

17

0.09 ± 0.002

HIV prevalence among non-sub-Saharan African countries with primarily homosexual or injection drug use HIV transmission (/100 adults)2

33

-1.03

0.29

25

0.41 ± 0.004

4

0.06 ± 0.001

Cervical cancer incidence (/100,000 women/year)

117

-7.2

0.18

51

35.0 ± 16.2

52

20.5 ± 12.8

Herpes Simplex Virus type-2 prevalence (/100 women)

23

-6.1

0.08

10

42.9 ± 13.8

9

30.2 ± 21.6

Tuberculosis prevalence (/100,000)

110

25.9

0.01

48

244 ± 191

49

296 ± 244

Hepatitis C prevalence (/100 adults)

75

0.20

0.003

37

3.17 ± 3.90

34

3.46 ± 3.81

Syphilis prevalence (/10,000 women)

43

51.7

0.0006

20

295 ± 235

14

284 ± 317

Malaria prevalence (/10,000)

94

-31.7

0.0007

31

385 ± 887

31

331 ± 596


SD – standard deviation.

* R2 values and mean values in bold type had p-values <0.001 and in italics type had p-values <0.05. R2 values and mean values not in bold or italics type had p-values >0.05.

1 Male circumcision prevalence was coded as 1 = low (<20%), 2 = intermediate (20–80%), and 3 = high (>80%).

2 Regression analyses presented as natural log of HIV (prevalence/100,000 adults).

Drain et al. BMC Infectious Diseases 2006 6:172   doi:10.1186/1471-2334-6-172

Open Data